Thatcher N - Search Results

1

Use of G-CSF during concurrent chemotherapy and thoracic radiotherapy in patients with limited-stage small-cell lung cancer safety data from a phase II trial.

Sheikh H, Colaco R, Lorigan P, Blackhall F, Califano R, Ashcroft L, Taylor P, Thatcher N, Faivre-Finn C. Sheikh H, et al. Among authors: thatcher n. Lung Cancer. 2011 Oct;74(1):75-9. doi: 10.1016/j.lungcan.2011.01.020. Epub 2011 Feb 26. Lung Cancer. 2011. PMID: 21353720 Clinical Trial.

2

Randomized phase III trial of dose-dense chemotherapy supported by whole-blood hematopoietic progenitors in better-prognosis small-cell lung cancer.

Lorigan P, Woll PJ, O'Brien ME, Ashcroft LF, Sampson MR, Thatcher N. Lorigan P, et al. Among authors: thatcher n. J Natl Cancer Inst. 2005 May 4;97(9):666-74. doi: 10.1093/jnci/dji114. J Natl Cancer Inst. 2005. PMID: 15870437 Clinical Trial.

3

Sequential platinum-based chemotherapy-thoracic radiotherapy in early stage non-small cell lung cancer.

Thatcher N, Faivre-Finn C, Blackhall F, Anderson H, Lorigan P. Thatcher N, et al. Clin Cancer Res. 2005 Jul 1;11(13 Pt 2):5051s-5056s. doi: 10.1158/1078-0432.CCR-05-9004. Clin Cancer Res. 2005. PMID: 16000613 Free article. Review.

4

Thoracic radiation therapy for limited-stage small-cell lung cancer: unanswered questions.

Faivre-Finn C, Lorigan P, West C, Thatcher N. Faivre-Finn C, et al. Among authors: thatcher n. Clin Lung Cancer. 2005 Jul;7(1):23-9. doi: 10.3816/CLC.2005.n.018. Clin Lung Cancer. 2005. PMID: 16098241 Review.

5

Pemetrexed in small-cell lung cancer: background and review of the ongoing GALES pivotal trial.

Ferraldeschi R, Thatcher N, Lorigan P. Ferraldeschi R, et al. Among authors: thatcher n. Expert Rev Anticancer Ther. 2007 May;7(5):635-40. doi: 10.1586/14737140.7.5.635. Expert Rev Anticancer Ther. 2007. PMID: 17492928 Review.

6

Modern management of small-cell lung cancer.

Ferraldeschi R, Baka S, Jyoti B, Faivre-Finn C, Thatcher N, Lorigan P. Ferraldeschi R, et al. Among authors: thatcher n. Drugs. 2007;67(15):2135-52. doi: 10.2165/00003495-200767150-00003. Drugs. 2007. PMID: 17927281 Review.

7

Management of unresectable stage III non-small-cell lung cancer with combined-modality therapy: a review of the current literature and recommendations for treatment.

Bayman NA, Blackhall F, Jain P, Lee L, Thatcher N, Faivre-Finn C. Bayman NA, et al. Among authors: thatcher n. Clin Lung Cancer. 2008 Mar;9(2):92-101. doi: 10.3816/CLC.2008.n.014. Clin Lung Cancer. 2008. PMID: 18501095 Review.

8

Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancer.

Eisen T, Thatcher N, Leyvraz S, Miller WH Jr, Couture F, Lorigan P, Lüthi F, Small D, Tanovic A, O'Brien M. Eisen T, et al. Among authors: thatcher n. Lung Cancer. 2009 Apr;64(1):60-5. doi: 10.1016/j.lungcan.2008.06.017. Epub 2008 Aug 9. Lung Cancer. 2009. PMID: 18692272 Clinical Trial.

9

Lung cancer after treatment for breast cancer.

Lorigan P, Califano R, Faivre-Finn C, Howell A, Thatcher N. Lorigan P, et al. Among authors: thatcher n. Lancet Oncol. 2010 Dec;11(12):1184-92. doi: 10.1016/S1470-2045(10)70056-5. Epub 2010 Jun 10. Lancet Oncol. 2010. PMID: 20541465 Review.

10

A phase I study of Vandetanib in combination with vinorelbine/cisplatin or gemcitabine/cisplatin as first-line treatment for advanced non-small cell lung cancer.

Blackhall FH, O'brien M, Schmid P, Nicolson M, Taylor P, Milenkova T, Kennedy SJ, Thatcher N. Blackhall FH, et al. Among authors: thatcher n. J Thorac Oncol. 2010 Aug;5(8):1285-8. doi: 10.1097/JTO.0b013e3181e3a2d1. J Thorac Oncol. 2010. PMID: 20661087 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

391 results

Search Page

Filters